EAS-LatAm webinar: How to improve the quality of care for patients with dyslipidemia?

Long-term adherence to lipid-lowering therapy poses one of the greatest challenges in cardiovascular prevention. The effectiveness of therapy heavily depends on the individualization of medical treatment, the identification and resolution of barriers that prevent full treatment adoption, and the implementation of best practices in medical services. Cultural issues and peculiarities of care delivery systems hinder the universal application of the same strategies.

This symposium will feature a review of the variability in the effectiveness of lipid-lowering therapy around the world. Additionally, examples of best practices implemented in Europe and Latin America will be described. All presentations will be given by highly recognized leaders in the field, representing the European Atherosclerosis Society and the EAS LATAM group.